Alvotech
ALVODrug Manufacturers - Specialty & Generic
$4.65−4.91%As of Oct 30vs prior close
- Market cap
- $1.7B
- P/E (TTM)
- 46.5×
- From 52W high
- −40.69%
- EPS (YE25)
- $0.10
- Revenue (YE25)
- $586.3M
- Net margin
- 4.76%
- Dividend yield
- 0.00%
Nomior Score
22
Steady ProfileSpeculativeBottom 8% of the scored universe
Growth55
Quality33
Value38
Momentum27
Resilience19
Growth
+54.49%revenue a year over 5 fiscal years
YE20 $66.6MYE25 $586.3M
Connections
Revenue to profitYE25
5% of revenue became net profit, up 52 pts on a year.